Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909075 · ClinicalTrials.gov registry record
A Study to Assess Thymic Function Using PET/CT and MRI
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT02909075: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02909075 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02909075 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and after the participants transplantation.
Interventions
- DEVICE MRI
- DEVICE PET/CT scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909075
The ClinicalTrials.gov registry entry for NCT02909075 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02909075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02909075 about?
NCT02909075 is a clinical study titled "A Study to Assess Thymic Function Using PET/CT and MRI". The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and aft...
What is the current status of trial NCT02909075?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2016-08. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02909075?
The interventions under investigation include: MRI (DEVICE), PET/CT scans (DEVICE).
Who is sponsoring clinical trial NCT02909075?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.